-
1994
Company Description
Immuron focuses on oral immunotherapy using polyclonal antibody products for humans.
Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.
-
Manufacturer:
Science and Engineering -
Formed:
1994 -
Company Website:
-
Company E-mail:
-
Company Address:
Suite 10- 25 Chapman Street, Blackburn NorthArmadaleAustralia -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits